Gene · 79109
Papers2,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular and structural basis for replication initiation and strand separation by human mitochondrial DNA polymerase γ. | Nucleic Acids Res | 2026 | 42788360 | PubTator, text mining | PubMed |
| Remineralization of Artificial Caries-like Lesions in Permanent Enamel by MI Paste One: Comparative Physicochemical Outcomes and In Vitro Resistance to Secondary Demineralization. | J Funct Biomater | 2026 | 42506559 | PubTator, text mining | PubMed |
| The role of mTORC2 in the in vitro neurotoxicity of Parkinsonian mimetics 6-OHDA and MPP. | Neurotoxicology | 2026 | 42320558 | PubTator, text mining | PubMed |
| GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis. | Int J Biol Sci | 2026 | 42157923 | PubTator, text mining | PubMed |
| Uremic Toxins and the Lung Alveolar Capillary Barrier: A Narrative Review. | Toxins (Basel) | 2026 | 41893549 | PubTator, text mining | PubMed |
| Structural and mechanistic basis of mTORC2 activation of protein kinase AKT/PKB. | Biochem J | 2026 | 41774454 | PubTator, text mining | PubMed |
| Comprehensive Review of Antiphospholipid Syndrome: Over Four Decades of Advances and Challenges. | Cells | 2026 | 41744799 | PubTator, text mining | PubMed |
| Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer. | Cancer Lett | 2026 | 41707978 | PubTator, text mining | PubMed |
| Involvement of Non-Muscle Myosin Light Chain Kinase Nitration in Molecular Regulation of Inflammation-Induced Endothelial Cell Barrier Dysfunction. | Cells | 2026 | 41677625 | PubTator, text mining | PubMed |
| The mTORC2 component SIN1 post-transcriptionally regulates TYMS levels and modulates P53 activity in response to 5-FU chemotherapy. | Cell Commun Signal | 2026 | 41606600 | PubTator, text mining | PubMed |
| The soluble G protein of respiratory syncytial virus promotes viral dissemination via TLR2-mediated NLRP3 priming and pyroptosis. | Npj Viruses | 2026 | 41593203 | PubTator, text mining | PubMed |
| RFC1 Repeat Expansion in Chronic Cough: Findings From the Korean Chronic Cough Registry. | Allergy Asthma Immunol Res | 2026 | 41592538 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Targeting the UFL1-AKT cascade suppresses triple-negative breast cancer progression. | Nat Commun | 2026 | 41559059 | PubTator, text mining | PubMed |
| LOTUS-domain proteins activate Vasa to drive germ granule assembly. | bioRxiv | 2026 | 41542423 | PubTator, text mining | PubMed |
| Development of a SIN1 Targeting Inhibitor as a Novel Therapeutic Approach for the Treatment of Malignancies. | Mol Cancer Ther | 2026 | 41423418 | PubTator, text mining | PubMed |
| Structural basis for the recruitment and selective phosphorylation of Akt by mTORC2. | Science | 2026 | 41308123 | PubTator, text mining | PubMed |
| Determination of Melatonin, Macrophage Inflammatory Protein-1, and Monocyte Chemoattractant Protein in Type 2 Diabetes Mellitus Individuals. | Ann Afr Med | 2026 | 41288113 | PubTator, text mining | PubMed |
| mTORC1/2 inhibition induces tumor regression in CDK4/6 inhibitor-insensitive acral melanoma. | Cancer Gene Ther | 2026 | 41286504 | PubTator, text mining | PubMed |
| Oxidative stress-mediated apoptosis via the SLC23A2-ascorbic acid interaction contributes to cleft lip development. | Front Pediatr | 2025 | 41113559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79109/papers